Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

SnET2 photodynamic therapy stabilizes visual acuity in subfoveal choroidal neovascularization

May 11, 1999

Ocufit SR provides sustained release of diclofenac into the sclera

May 11, 1999

AGN-192024 is more effective than timolol in lowering IOP in patients with glaucoma

May 11, 1999

InSite Vision signs agreement with U. of California for glaucoma gene rights

May 4, 1999

Allergen patents new thromboxane receptor ligands with particular utility in ocular hypertension

May 3, 1999

Alcon to continue Lu-Tex development

April 27, 1999

Steroidogenesis inhibitor tested in mouse model of hereditary blindness

April 15, 1999

Eye implant receives FDA approval for correcting mild myopia

April 13, 1999

PhotoVision in-licenses novel technology for development of AMD treatment

April 7, 1999

Xalatan approved in Japan for glaucoma and ocular hypertension

March 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...